0001493152-20-022153.txt : 20201120 0001493152-20-022153.hdr.sgml : 20201120 20201120180012 ACCESSION NUMBER: 0001493152-20-022153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201120 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wider Todd CENTRAL INDEX KEY: 0001642715 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 201333694 MAIL ADDRESS: STREET 1: 4848 LEMMON AVENUE, SUITE 517 CITY: DALLAS STATE: TX ZIP: 75219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2020-11-20 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001642715 Wider Todd 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 1 0 0 0 Stock Option (right to buy) 1.28 2020-11-20 4 A 0 21518 A 2030-05-20 Common Stock 21518 21518 D Stock Option (right to buy) 3.20 2020-11-20 4 D 0 21518 D 2030-05-20 Common Stock 21518 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 19827 A 2029-05-21 Common Stock 19827 19827 D Stock Option (right to buy) 7.42 2020-11-20 4 D 0 19827 D 2029-05-21 Common Stock 19827 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 50000 A 2028-03-29 Common Stock 50000 50000 D Stock Option (right to buy) 13.65 2020-11-20 4 D 0 50000 D 2028-03-29 Common Stock 50000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 30000 A 2027-12-14 Common Stock 30000 30000 D Stock Option (right to buy) 16.00 2020-11-20 4 D 0 30000 D 2027-12-14 Common Stock 30000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 50000 A 2026-12-13 Common Stock 50000 50000 D Stock Option (right to buy) 4.45 2020-11-20 4 D 0 50000 D 2026-12-13 Common Stock 50000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 50000 A 2026-02-11 Common Stock 50000 50000 D Stock Option (right to buy) 2.31 2020-11-20 4 D 0 50000 D 2026-02-11 Common Stock 50000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 100000 A 2025-05-11 Common Stock 100000 100000 D Stock Option (right to buy) 7.34 2020-11-20 4 D 0 100000 D 2025-05-11 Common Stock 100000 0 D The options vest 100% on November 20, 2020. The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price. The options vested 100% on November 21, 2019. The options vested 100% on September 29, 2018. The options vested 100% on June 14, 2018. The options vested 100% on June 13, 2017. The options vested 100% on August 11, 2016. The options vested 100% on November 11, 2015. /s/ Brendan M. O'Malley, as Attorney-in-fact 2020-11-20